CIK 0001806952
- Non-accelerated filer
- Smaller reporting company
Lyell Immunopharma, Inc.
Sign in to watch- Ticker
- LYEL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 833006753
- Phone
- +1 650-695-0677
- Business address
- 201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale President and CEO sold 7,455 shares at $23.39 ($174,372)
- 4 Open-market sale Chief Operating Officer sold 1,236 shares at $23.39 ($28,910)
- 4 Open-market sale Chief Scientific Officer sold 1,671 shares at $23.39 ($39,085)
- 4 Open-market sale Chief Operating Officer sold 109 shares at $23.12 ($2,520)
- 4 Open-market sale Chief Scientific Officer sold 147 shares at $23.12 ($3,399)
- 4 Open-market sale President and CEO sold 438 shares at $23.12 ($10,127)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale VP, Corporate Controller sold 254 shares at $23.12 ($5,872)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale VP, Corporate Controller sold 2,072 shares at an average $35.80 ($74,181)
- 4 Open-market sale President and CEO sold 412 shares at $16.11 ($6,637)
- 4 Open-market sale VP, Corporate Controller sold 239 shares at $16.10 ($3,848)
- 4 Open-market sale Chief Scientific Officer sold 138 shares at $16.16 ($2,230)
- 4 Open-market sale Chief Operating Officer sold 95 shares at $16.12 ($1,531)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 7,257 shares at $10.54 ($76,518)
- 4 Open-market sale Chief Operating Officer sold 1,004 shares at $10.54 ($10,586)
Page 3 of 9 · 173 filings